The new results show a 10% absolute difference in survival benefit with erlotinib maintenance therapy, compared with placebo, at 3 years. Medscape Medical News
Atrial fibrillation was more likely to develop in diabetics than in nondiabetics in a new observational study, and the link was particularly strong in women. Heartwire
A new meta-analysis fails to find an association between a variation of the serotonin transporter gene, stressful life events, and depression. Medscape Medical News